Published in J Pharmacol Exp Ther on June 11, 2010
Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev (2011) 2.14
Ivermectin reduces alcohol intake and preference in mice. Neuropharmacology (2012) 1.02
Alcohol-binding sites in distinct brain proteins: the quest for atomic level resolution. Alcohol Clin Exp Res (2011) 0.99
Implication of the purinergic system in alcohol use disorders. Alcohol Clin Exp Res (2011) 0.98
Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis (2012) 0.93
Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin. Int J Neuropsychopharmacol (2012) 0.92
Ethanol is a fast channel inhibitor of P2X4 receptors. J Pharmacol Exp Ther (2011) 0.90
Pharmacologically targeting the P2rx4 gene on maintenance and reinstatement of alcohol self-administration in rats. Pharmacol Biochem Behav (2011) 0.90
Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders. Int J Neuropsychopharmacol (2014) 0.88
Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice. Neurochem Res (2014) 0.85
Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors. Purinergic Signal (2013) 0.84
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders. Front Neurosci (2014) 0.81
Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders. Alcohol Clin Exp Res (2012) 0.81
P2X4 receptor regulates alcohol-induced responses in microglia. J Neuroimmune Pharmacol (2014) 0.81
Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder. Alcohol (2015) 0.80
A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. Alcohol Clin Exp Res (2016) 0.77
Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors. J Neurochem (2016) 0.75
Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder. Neuropharmacology (2016) 0.75
Involvement of Purinergic P2X4 Receptors in Alcohol Intake of High-Alcohol-Drinking (HAD) Rats. Alcohol Clin Exp Res (2015) 0.75
P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology. Front Pharmacol (2017) 0.75
Molecular physiology of P2X receptors. Physiol Rev (2002) 13.61
Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature (2009) 4.18
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol (2005) 2.90
avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J (1997) 2.55
Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci (1999) 2.10
Distinct Localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci (2001) 1.97
Subunit arrangement in P2X receptors. J Neurosci (2003) 1.93
Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol (2009) 1.81
P2X receptors and nociception. Pharmacol Rev (2001) 1.80
Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem (2001) 1.70
Gating the pore of P2X receptor channels. Nat Neurosci (2008) 1.70
Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron (2007) 1.62
Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol (2004) 1.57
Introduction: P2 receptors. Curr Top Med Chem (2004) 1.53
Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes. J Mol Biol (2004) 1.48
Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther (2000) 1.26
Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Mol Pharmacol (2005) 1.20
A cation-pi interaction in the binding site of the glycine receptor is mediated by a phenylalanine residue. J Neurosci (2008) 1.18
Side-chain interactions between sulfur-containing amino acids and phenylalanine in alpha-helices. Biochemistry (1995) 1.17
Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity. J Biol Chem (2009) 1.16
Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design. Curr Top Med Chem (2007) 1.16
Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol Clin Exp Res (2002) 1.16
Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun (2006) 1.12
Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes. Neuropharmacology (2005) 1.10
Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J (2003) 1.09
Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors. Brain Res Mol Brain Res (1999) 1.08
Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch (2008) 1.08
Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. Biochem Pharmacol (2009) 1.06
Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes. Br J Pharmacol (2000) 1.05
Dissecting the facilitator and inhibitor allosteric metal sites of the P2X4 receptor channel: critical roles of CYS132 for zinc potentiation and ASP138 for copper inhibition. J Biol Chem (2007) 1.04
Behavioral effects of ivermectin in mice. Lab Anim Sci (1999) 0.99
Avermectin intoxication with coma, myoclonus, and polyneuropathy. Clin Toxicol (Phila) (2009) 0.96
A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors. J Neurochem (2009) 0.95
Ivermectin and filariasis. Fundam Clin Pharmacol (2003) 0.94
Ivermectin: an assessment of its pharmacology, microbiology and safety. Vet Hum Toxicol (2000) 0.94
The mechanism by which ethanol inhibits rat P2X4 receptors is altered by mutation of histidine 241. Br J Pharmacol (2005) 0.93
Acetylcholine and alcohol sensitivity of neuronal nicotinic acetylcholine receptors: mutations in transmembrane domains. Alcohol Clin Exp Res (2002) 0.91
Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors. Neuropharmacology (2008) 0.90
Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice. J Vet Pharmacol Ther (2009) 0.90
Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci (2005) 2.91
Coupling of agonist binding to channel gating in the GABA(A) receptor. Nature (2003) 2.89
Ethanol's molecular targets. Sci Signal (2008) 2.06
Structural basis for alcohol modulation of a pentameric ligand-gated ion channel. Proc Natl Acad Sci U S A (2011) 1.52
Microsecond simulations indicate that ethanol binds between subunits and could stabilize an open-state model of a glycine receptor. Biophys J (2011) 1.42
Evidence that ethanol acts on a target in Loop 2 of the extracellular domain of alpha1 glycine receptors. J Neurochem (2007) 1.26
Charged residues in the beta2 subunit involved in GABAA receptor activation. J Biol Chem (2003) 1.18
Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity. J Biol Chem (2009) 1.16
Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol Clin Exp Res (2002) 1.16
Sites of excitatory and inhibitory actions of alcohols on neuronal alpha2beta4 nicotinic acetylcholine receptors. J Pharmacol Exp Ther (2003) 1.14
The common chemical motifs within anesthetic binding sites. Anesth Analg (2007) 1.13
Channel gating of the glycine receptor changes accessibility to residues implicated in receptor potentiation by alcohols and anesthetics. J Biol Chem (2004) 1.10
Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes. Neuropharmacology (2005) 1.10
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists. J Biol Chem (2004) 1.09
Tryptophan scanning mutagenesis in TM4 of the GABA(A) receptor alpha1 subunit: implications for modulation by inhaled anesthetics and ion channel structure. Neuropharmacology (2002) 1.08
Accessibility to residues in transmembrane segment four of the glycine receptor. Neuropharmacology (2005) 1.08
Cross-linking of sites involved with alcohol action between transmembrane segments 1 and 3 of the glycine receptor following activation. J Neurochem (2007) 1.08
Modeling anesthetic binding sites within the glycine alpha one receptor based on prokaryotic ion channel templates: the problem with TM4. J Chem Inf Model (2010) 1.05
General anesthetics have additive actions on three ligand gated ion channels. Anesth Analg (2008) 1.03
Molecular targets and mechanisms for ethanol action in glycine receptors. Pharmacol Ther (2010) 1.03
Endothelial fate mapping in mice with pulmonary hypertension. Circulation (2013) 1.02
Targets for ethanol action and antagonism in loop 2 of the extracellular domain of glycine receptors. J Neurochem (2008) 1.02
Ivermectin reduces alcohol intake and preference in mice. Neuropharmacology (2012) 1.02
Homology modeling of a human glycine alpha 1 receptor reveals a plausible anesthetic binding site. J Chem Inf Model (2005) 1.01
Anesthetic and ethanol effects on spontaneously opening glycine receptor channels. J Neurochem (2002) 1.00
Zinc enhances ethanol modulation of the alpha1 glycine receptor. Neuropharmacology (2009) 0.99
Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols. J Pharmacol Exp Ther (2011) 0.99
Alcohol-binding sites in distinct brain proteins: the quest for atomic level resolution. Alcohol Clin Exp Res (2011) 0.99
Implication of the purinergic system in alcohol use disorders. Alcohol Clin Exp Res (2011) 0.98
Cross-linking of glycine receptor transmembrane segments two and three alters coupling of ligand binding with channel opening. J Neurochem (2004) 0.97
Normal-mode analysis of the glycine alpha1 receptor by three separate methods. J Chem Inf Model (2007) 0.96
A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors. J Neurochem (2009) 0.95
Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action. J Pharmacol Exp Ther (2008) 0.95
Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1. Pharm Res (2003) 0.95
Molecular mechanism for the dual alcohol modulation of Cys-loop receptors. PLoS Comput Biol (2012) 0.95
Multiple sites of ethanol action in alpha1 and alpha2 glycine receptors suggested by sensitivity to pressure antagonism. J Neurochem (2004) 0.95
Ethanol potentiation of glycine receptors expressed in Xenopus oocytes antagonized by increased atmospheric pressure. Alcohol Clin Exp Res (2003) 0.94
A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1. Pharm Res (2006) 0.94
A transmembrane amino acid in the GABAA receptor β2 subunit critical for the actions of alcohols and anesthetics. J Pharmacol Exp Ther (2010) 0.94
Disruption of an intersubunit electrostatic bond is a critical step in glycine receptor activation. Proc Natl Acad Sci U S A (2010) 0.93
Evaluation of a proposed mechanism of ligand-gated ion channel activation in the GABAA and glycine receptors. Neurosci Lett (2004) 0.93
Alanine-scanning mutagenesis in the signature disulfide loop of the glycine receptor alpha 1 subunit: critical residues for activation and modulation. Biochemistry (2004) 0.93
Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter. Pharm Res (2009) 0.93
Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin. Int J Neuropsychopharmacol (2012) 0.92
Ethanol is a fast channel inhibitor of P2X4 receptors. J Pharmacol Exp Ther (2011) 0.90
Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors. Neuropharmacology (2008) 0.90
Roles for loop 2 residues of alpha1 glycine receptors in agonist activation. J Biol Chem (2008) 0.90
Charge and geometry of residues in the loop 2 β hairpin differentially affect agonist and ethanol sensitivity in glycine receptors. J Pharmacol Exp Ther (2012) 0.90
Seeking structural specificity: direct modulation of pentameric ligand-gated ion channels by alcohols and general anesthetics. Pharmacol Rev (2014) 0.90
Assessment of homology templates and an anesthetic binding site within the γ-aminobutyric acid receptor. Anesthesiology (2013) 0.90
Stabilization of the GluCl ligand-gated ion channel in the presence and absence of ivermectin. Biophys J (2013) 0.90
Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors. Biochemistry (2006) 0.89
Are sobriety and consciousness determined by water in protein cavities? Alcohol Clin Exp Res (2004) 0.89
Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol. Alcohol Clin Exp Res (2013) 0.88
GABA(A) receptor transmembrane amino acids are critical for alcohol action: disulfide cross-linking and alkyl methanethiosulfonate labeling reveal relative location of binding sites. J Neurochem (2013) 0.88
Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives. Biochemistry (2003) 0.88
Effect of cobratoxin binding on the normal mode vibration within acetylcholine binding protein. J Chem Inf Model (2008) 0.86
Mutation of a zinc-binding residue in the glycine receptor α1 subunit changes ethanol sensitivity in vitro and alcohol consumption in vivo. J Pharmacol Exp Ther (2012) 0.86
Inhibition versus potentiation of ligand-gated ion channels can be altered by a single mutation that moves ligands between intra- and intersubunit sites. Structure (2013) 0.85
Zinc-dependent modulation of α2- and α3-glycine receptor subunits by ethanol. Alcohol Clin Exp Res (2013) 0.85
Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice. Neurochem Res (2014) 0.85
Identifying the binding site(s) for antidepressants on the Torpedo nicotinic acetylcholine receptor: [3H]2-azidoimipramine photolabeling and molecular dynamics studies. Biochim Biophys Acta (2008) 0.84
Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptor. Int Rev Neurobiol (2003) 0.84
Effects of the abused solvent toluene on recombinant P2X receptors expressed in HEK293 cells. Brain Res Mol Brain Res (2004) 0.83
Effects of ethanol on adenosine 5'-triphosphate-gated purinergic and 5-hydroxytryptamine receptors. Alcohol Clin Exp Res (2006) 0.83
Cysteine scanning of transmembrane domain three of the human dipeptide transporter: implications for substrate transport. J Drug Target (2007) 0.82
The TM2 6' position of GABA(A) receptors mediates alcohol inhibition. J Pharmacol Exp Ther (2011) 0.82
Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice. Neuropsychopharmacology (2013) 0.80
Normal mode gating motions of a ligand-gated ion channel persist in a fully hydrated lipid bilayer model. ACS Chem Neurosci (2010) 0.79
Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans. Neuroreport (2014) 0.79
Functional role of the intracellular loop linking transmembrane domains 6 and 7 of the human dipeptide transporter hPEPT1. J Membr Biol (2010) 0.78
Benzodiazepine agonist and inverse agonist coupling in GABAA receptors antagonized by increased atmospheric pressure. Eur J Pharmacol (2003) 0.77
The minimum alveolar anesthetic concentration of 2-, 3-, and 4-alcohols and ketones in rats: relevance to anesthetic mechanisms. Anesth Analg (2006) 0.76